Nouvelles - Bioventus

juillet 11, 2013

Bioventus Names Alessandra Pavesio New Chief Science Officer DURHAM, N.C. – July 11, 2013 – Bioventus, a leader in active orthopaedic healing, today…

juillet 4, 2013

Bioventus Announces European Launch of Next Generation EXOGEN Device HOOFDDORP, THE NETHERLANDS – (July 4, 2013) – Bioventus, a global leader in…

juillet 1, 2013

Bioventus Launches Company in Australia and Poland HOOFDDORP, THE NETHERLANDS – (July 1, 2013) – Bioventus, a global leader in active orthopaedic…

juillet 1, 2013

Bioventus Acquires Exclusive Rights to Pfizer's BMP Portfolio DURHAM, N.C. – July 1, 2013 – Bioventus, a leader in active orthopaedic healing, today…

juillet 1, 2013

NTAC Releases Adoption Pack to Assist Implementation of NICE Guidelines Supporting the Use of EXOGEN HOOFDDORP, THE NETHERLANDS – (May 13, 2013) –…

mai 6, 2013

Bioventus Opens Operations in Germany HOOFDDORP, THE NETHERLANDS – (May 6, 2013) – At the one-year anniversary of Bioventus forming in the United…

avril 8, 2013

Bioventus Appoints Dr. Peter Heeckt Chief Medical Officer DURHAM, N.C. – April 8, 2013 – Bioventus, a leader in active orthopaedic healing, today…

avril 7, 2013

Bioventus Expands to Canada, France and Finland HOOFDDORP, THE NETHERLANDS – (April 2, 2013) – Bioventus, a global leader in active orthopaedic…

mars 14, 2013

Bioventus Launches Company in the UK, Ireland, Sweden, Norway and Denmark HOOFDDORP, THE NETHERLANDS – (March 4, 2013) – Bioventus, a global leader…

janvier 23, 2013

UK’s NICE Offers Guidance Supporting EXOGEN Device DURHAM, NC - New guidance from a British health agency released earlier this month supports the…

Salle de presse